Motley Fool Australia

ResMed Inc (ASX: RMD) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $8.74 billion
P/E Ratio 41.32
Dividend Yield 0.90%
Shares Outstanding 1.46 billion
Earnings per share 0.479
Dividend per share 0.20
Year To Date Return -7.86%
Earnings Yield 2.42%
Franking N/A

Resmed Inc. (ASX: RMD) Latest News

Ideas and innovation

Why ResMed (ASX:RMD) shares could be a fantastic buy and hold option

More »

dice labelled buy and sell rolling on a sharemarket chart

2 ASX shares rated as buys by brokers

More »

Clock showing time to buy, ASX 200 shares

Leading brokers name 3 ASX shares to buy today

More »

asx share price falling represented by graph of paper plane trending down

Why Afterpay, ResMed, Temple & Webster, & Worley shares are dropping lower

More »

Woman investor looking at ASX financial results on laptop

3 very impressive ASX quarterly updates from last week

More »

Investment stock market Entrepreneur Business Man discussing and analysis graph stock market trading,stock chart concept

ASX 200 up 0.6%: ResMed Q2 update, Kogan sinks, NAB acquires 86 400

More »

hand on touch screen lit up by a share price chart moving higher

Why Lynas, Mesoblast, ResMed, & Service Stream shares are pushing higher

More »

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market

ResMed (ASX:RMD) share price on watch after solid Q2 update

More »

Dividend Payment History

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
17 Aug 2016 $0.0300 0.00% Final 22 Sep 2016

Yearly Dividend Payment Chart

Data provided by Morningstar.

About ResMed Inc (ASX: RMD)

Resmed Inc. (ASX: RMD) is a global healthcare company operating in the respiratory medical device space, particularly in the treatment of sleep apnoea.

The company is headquartered in San Diego, California, and develops and manufactures medical devices and cloud-based software applications that diagnose, treat and manage a number of respiratory disorders. These include sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.

Resmed operates in more than 140 countries worldwide and has manufacturing facilities in Australia, Singapore, France, and the United States.

Resmed first listed on the ASX on 25 Nov 1999 and is now recognised as a blue chip healthcare share on the ASX 200 index.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
26 Feb 2021 $24.55 $-0.50 -2.00% 632,006 $24.90 $25.04 $24.28
25 Feb 2021 $25.05 $0.01 0.04% 675,455 $25.09 $25.19 $25.01
24 Feb 2021 $25.04 $-0.29 -1.14% 1,044,170 $25.25 $25.29 $24.92
23 Feb 2021 $25.33 $0.09 0.36% 660,962 $25.11 $25.46 $25.07
22 Feb 2021 $25.24 $-0.57 -2.21% 486,175 $25.43 $25.50 $25.18
19 Feb 2021 $25.81 $0.44 1.73% 770,676 $25.60 $25.95 $25.60
18 Feb 2021 $25.37 $0.50 2.01% 1,044,151 $25.36 $25.53 $25.29
17 Feb 2021 $24.87 $-1.10 -4.24% 813,184 $25.20 $25.25 $24.85
16 Feb 2021 $25.97 $0.12 0.46% 478,467 $25.92 $26.01 $25.74
15 Feb 2021 $25.85 $0.09 0.35% 365,156 $25.76 $25.94 $25.72
12 Feb 2021 $25.76 $-0.15 -0.58% 313,503 $25.84 $25.94 $25.68
11 Feb 2021 $25.91 $-0.15 -0.58% 477,650 $25.98 $26.04 $25.87
10 Feb 2021 $26.06 $-0.09 -0.34% 479,888 $25.96 $26.10 $25.84
09 Feb 2021 $26.15 $-0.20 -0.76% 507,831 $26.06 $26.28 $26.05
08 Feb 2021 $26.35 $-0.35 -1.31% 2,022,255 $26.40 $26.49 $26.29
05 Feb 2021 $26.70 $0.18 0.68% 672,255 $26.90 $26.97 $26.55
04 Feb 2021 $26.52 $-0.17 -0.64% 822,560 $26.60 $26.66 $26.41
03 Feb 2021 $26.69 $0.34 1.29% 1,362,114 $26.99 $27.18 $26.61
02 Feb 2021 $26.35 $-0.28 -1.05% 1,365,658 $26.46 $26.60 $26.24
01 Feb 2021 $26.63 $-0.59 -2.17% 1,305,082 $26.44 $26.69 $26.06
29 Jan 2021 $27.22 $-0.20 -0.73% 857,610 $27.70 $27.99 $27.21
28 Jan 2021 $27.42 $-1.16 -4.06% 1,057,003 $27.51 $27.68 $27.17
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Peter Craig Farrell Non-Executive Director,Non-Executive Chairman Jul 2002
Mr Ronald R Taylor Non-Executive Director Jan 2005
Mr Richard Sulpizio Non-Executive Director Aug 2005
Mr Michael J Farrell Chief Executive Officer,Executive Director Mar 2013
Ms Carol Burt Non-Executive Director Aug 2014
Ms Karen Drexler Non-Executive Director Aug 2018
Mr Jan De Witte Non-Executive Director May 2019
Ms Harjit Gill Non-Executive Director Nov 2018
Mr David Pendarvis Company Secretary
Brett Sandercock Chief Financial Officer
David Pendarvis Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Not disclosed in Annual Report 0 0.00%